699 RISK OF P53 EXPRESSION IN UPPER URINARY TRACT UROTHELIAL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

2013 ◽  
Vol 189 (4S) ◽  
Author(s):  
Joo Yong Lee ◽  
Ki-Seok Jang ◽  
Kang Su Cho ◽  
Seung Wook Lee ◽  
Hong Sang Moon ◽  
...  
2018 ◽  
Vol 16 (4) ◽  
pp. e831-e841 ◽  
Author(s):  
Chihyun Ahn ◽  
Chang Wook Jeong ◽  
Cheol Kwak ◽  
Hyeon Hoe Kim ◽  
Hyung Suk Kim ◽  
...  

2013 ◽  
Vol 11 (3) ◽  
pp. 221-228 ◽  
Author(s):  
Ja Hyeon Ku ◽  
Seok-Soo Byun ◽  
Hyeon Jeong ◽  
Cheol Kwak ◽  
Hyeon Hoe Kim ◽  
...  

2014 ◽  
Vol 94 (1) ◽  
pp. 50-57 ◽  
Author(s):  
Joo Yong Lee ◽  
Kang Su Cho ◽  
Richilda Red Diaz ◽  
Young Deuk Choi ◽  
Hong Yong Choi

Objective: To conduct a meta-analysis examining p53 expression as a potential risk factor in upper urinary tract urothelial carcinoma (UUT-UC) and to systematically review the available data. Methods: A comprehensive literature review was performed from January 1991 to August 2012, using search engines such as PubMed, EMBASE, Cochrane Library and KoreaMed. All retrieved references were manually reviewed, and two authors independently extracted the data. The quality of case-control and cohort studies was assessed using the Scottish Intercollegiate Guidelines Network (SIGN) checklists. Heterogeneity among studies was examined using the Q statistics and Higgins' I2 statistic. Results: Of 302 abstracts of original research studies, nine case-control trials fit our criteria for inclusion in the analysis. Of the nine articles included, four scored ‘low' and five scored ‘modest' in the quality assessment performed according to the SIGN checklists. Analysis of the correlation between different factors and p53 expression in UUT-UC showed that pathologic stage (≥pT3 or <pT3) differed significantly between the p53 and non-p53 groups (OR = 2.720, p < 0.001). Statistically significant correlations were also detected between p53 expression and histologic grade (OR = 4.507, p < 0.001) and female gender (OR = 2.724, p < 0.001). Conclusion: The results of our meta-analysis suggest that p53 expression in UUT-UC was correlated with advanced pathologic stage, high histologic grade and female gender.


2018 ◽  
Vol 128 ◽  
pp. 58-64 ◽  
Author(s):  
Richard W. Gregg ◽  
Francisco E. Vera-Badillo ◽  
Christopher M. Booth ◽  
Aamer Mahmud ◽  
Michael Brundage ◽  
...  

2021 ◽  
Vol 8 ◽  
Author(s):  
Guihong Liu ◽  
Zeqin Yao ◽  
Guoqiang Chen ◽  
Yalang Li ◽  
Bing Liang

Background: In this meta-analysis, we will focus on evaluating the effects of open nephroureterectomy compared with laparoscopic nephroureterectomy on postoperative results in upper urinary tract urothelial carcinoma subjects.Methods: A systematic literature search up to January 2021 was performed, and 36 studies included 23,013 subjects with upper urinary tract urothelial carcinoma at the start of the study; of them, 8,178 were laparoscopic nephroureterectomy, and 14,835 of them were open nephroureterectomy. They were reporting relationships between the efficacy and safety of open nephroureterectomy compared with laparoscopic nephroureterectomy in the treatment of upper urinary tract urothelial carcinoma. We calculated the odds ratio (OR) or the mean difference (MD) with 95% CIs to evaluate the efficacy and safety of open nephroureterectomy compared with laparoscopic nephroureterectomy in the treatment of upper urinary tract urothelial carcinoma using the dichotomous or continuous method with a random or fixed-effect model.Results: Laparoscopic nephroureterectomy in subjects with upper urinary tract urothelial carcinoma was significantly related to longer operation time (MD, 43.90; 95% CI, 20.91–66.90, p &lt; 0.001), shorter hospital stay (MD, −1.71; 95% CI, −2.42 to −1.00, p &lt; 0.001), lower blood loss (MD, −133.82; 95% CI, −220.92 to −46.73, p = 0.003), lower transfusion need (OR, 0.56; 95% CI, 0.47–0.67, p &lt; 0.001), and lower overall complication (OR, 0.79; 95% CI, 0.70–0.90, p &lt; 0.001) compared with open nephroureterectomy.However, no significant difference was found between laparoscopic nephroureterectomy and open nephroureterectomy in subjects with upper urinary tract urothelial carcinoma in 2–5 years recurrence-free survival (OR, 0.90; 95% CI, 0.69–1.18, p = 0.46), 2–5 years cancer-specific survival (OR, 0.94; 95% CI, 0.69–1.28, p = 0.68), and 2–5 years overall survival (OR, 1.31; 95% CI, 0.91–1.87, p = 0.15).Conclusion: Laparoscopic nephroureterectomy in subjects with upper urinary tract urothelial carcinoma may have a longer operation time, shorter hospital stay, and lower blood loss, transfusion need, and overall complication compared to open nephroureterectomy. Further studies are required to validate these findings.


Sign in / Sign up

Export Citation Format

Share Document